Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price shot up 5.6% during mid-day trading on Monday . The company traded as high as $8.55 and last traded at $8.51. 851,636 shares changed hands during trading, a decline of 73% from the average session volume of 3,192,473 shares. The stock had previously closed at […]
Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $17.00 price objective on the stock. Other analysts have also issued research reports about the company. KeyCorp boosted their price target on Recursion Pharmaceuticals from […]
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Bayer AG - Digital Transformation Strategies" report has been added to ResearchAndMarkets.com's...